ZA936723B - Pharmaceutical preparations for lowering homocysteine levels - Google Patents
Pharmaceutical preparations for lowering homocysteine levelsInfo
- Publication number
- ZA936723B ZA936723B ZA936723A ZA936723A ZA936723B ZA 936723 B ZA936723 B ZA 936723B ZA 936723 A ZA936723 A ZA 936723A ZA 936723 A ZA936723 A ZA 936723A ZA 936723 B ZA936723 B ZA 936723B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical preparations
- homocysteine levels
- lowering homocysteine
- lowering
- levels
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA926990 | 1992-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA936723B true ZA936723B (en) | 1995-08-14 |
Family
ID=25582104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA936723A ZA936723B (en) | 1992-09-14 | 1993-09-13 | Pharmaceutical preparations for lowering homocysteine levels |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0595005A1 (fr) |
JP (1) | JPH06192105A (fr) |
CN (1) | CN1087517A (fr) |
CA (1) | CA2105177A1 (fr) |
ZA (1) | ZA936723B (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0689834A3 (fr) | 1994-07-01 | 1996-06-05 | Willem Jacob Serfontein | Additif alimentaire pour l'homme ou les animaux contenant des vitamines et des sels minéraux à libération prolongée |
CA2199005A1 (fr) * | 1994-09-01 | 1996-03-07 | Emile Bourland (Deceased) | Compositions et procedes d'administration de polypeptides |
US5932624A (en) * | 1995-10-17 | 1999-08-03 | Herbert; Victor D. | Vitamin supplement composition |
US6265391B1 (en) | 1995-10-17 | 2001-07-24 | Upsher-Smith Laboratories, Inc. | Method for preventing peripheral nerve damage |
CN1122456C (zh) * | 1996-01-31 | 2003-10-01 | 南亚拉巴马医学科学基金会 | 含有天然的还原叶酸盐异构体的食品和维生素制品 |
DE19649730A1 (de) * | 1996-08-08 | 1998-02-12 | Eu Rho Pharma Gmbh | Mittel zur Stärkung des menschlichen Organismus |
US6008221A (en) * | 1996-11-06 | 1999-12-28 | Bristol-Myers Squibb Company | Method for treating Alzheimer's disease with folic acid |
CH693255A5 (de) * | 1997-06-13 | 2003-05-15 | Eprova Ag | Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels. |
DE19812753C1 (de) * | 1998-03-23 | 1999-09-09 | Schieffer Arzneimittel Gmbh Dr | Zusammensetzung zur pharmazeutischen Anwendung und/oder zur Ernährungsergänzung bei Mensch oder Tier |
AU4555799A (en) * | 1998-06-12 | 1999-12-30 | Craig Anthony Cooney | Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring |
US6475514B1 (en) | 1998-12-03 | 2002-11-05 | Andrew Blitzer | Athletic patch |
US6210686B1 (en) * | 1998-12-18 | 2001-04-03 | Beth Israel Deaconess Medical Center | Dietary supplement and method for lowering risk of heart disease |
US6914073B2 (en) * | 1999-03-18 | 2005-07-05 | Bristol Myers Squibb Company | Vitamin formulation for cardiovascular health |
GB9906740D0 (en) * | 1999-03-23 | 1999-05-19 | Kilgowan Limited | Oral combinations of hydroxocobalamin and folic acid |
NZ517466A (en) * | 1999-09-02 | 2003-11-28 | Nostrum Pharmaceuticals Inc | Controlled release oral dosage suitable for oral administration |
FI19992239A (fi) * | 1999-10-18 | 2001-04-19 | Jurilab Ltd Oy | Ravintotäydennys |
WO2001030352A1 (fr) * | 1999-10-28 | 2001-05-03 | Cary Pharmaceuticals Inc. | Acide folique a dose elevee aux fins du traitement de l'hyperhomocysteinemie |
DE10053155A1 (de) * | 2000-10-26 | 2002-05-08 | Erika Jungkeit | Verwendung eines Multivitaminpräparats zur Behandlung der Schuppenflechte |
JP2004538262A (ja) * | 2000-12-14 | 2004-12-24 | タフツ ユニバーシティー | 関節炎状態を治療するための化合物および方法 |
WO2004006919A1 (fr) * | 2002-07-11 | 2004-01-22 | Sankyo Company, Limited | Composition medicale pour reduire le taux de lipides sanguins ou le taux d'homocysteine sanguine |
JP4611622B2 (ja) * | 2002-07-11 | 2011-01-12 | 第一三共株式会社 | 血中脂質改善又は血中ホモシステイン低下のための医薬組成物 |
JP2004231585A (ja) * | 2002-12-05 | 2004-08-19 | Fancl Corp | 生体内ホモシステインレベル低減用および上昇抑制用組成物 |
EP1937269A1 (fr) * | 2004-05-09 | 2008-07-02 | Amal Mohamed Zakaria Al-Ansary | Procede d'elaboration de formulations contraceptives |
US20050272691A1 (en) * | 2004-06-04 | 2005-12-08 | Eaton Kevin P | Treatment of dermatological conditions |
DE102005001479A1 (de) * | 2005-01-12 | 2006-07-20 | Synavit Gmbh | Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung |
DE102005009379A1 (de) | 2005-03-01 | 2006-09-07 | Synavit Gmbh | Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung |
CN100349578C (zh) * | 2005-04-29 | 2007-11-21 | 朱舜时 | 治疗萎缩性胃炎的药物组合物 |
JP2007106703A (ja) * | 2005-10-14 | 2007-04-26 | Nutri Kk | 血管障害の予防および治療組成物 |
US7282225B1 (en) | 2006-09-27 | 2007-10-16 | Occular Technologies, Inc. | Composition and methods for improving retinal health |
DE102007003795A1 (de) * | 2007-01-25 | 2008-07-31 | Phrontier S.A.R.L. | Verwendung von Folsäure, Vitamin B6 und Vitamin B12 |
CN104224835A (zh) * | 2007-10-25 | 2014-12-24 | 营养株式会社 | 用于降低血中的糖、丙二醛修饰ldl、同型半胱氨酸和/或c反应蛋白的组合物 |
CN101584380B (zh) * | 2009-06-19 | 2011-08-10 | 山西新立源生物科技有限公司 | 复合甜菜碱的制备方法 |
CN102898321B (zh) * | 2011-07-24 | 2015-10-28 | 上海海嘉诺医药发展股份有限公司 | 一种制备n-丁氧草酰丙氨酸丁酯的方法 |
CN102429920A (zh) * | 2011-11-30 | 2012-05-02 | 胡志超 | 一种多关联降血酸组合物及其制备方法 |
EP2674159B1 (fr) * | 2012-06-15 | 2016-04-27 | Phrontier S.A.R.L. | Composition pharmaceutique pour la régénération du foie |
WO2017060320A1 (fr) * | 2015-10-07 | 2017-04-13 | Dsm Ip Assets B.V. | Extrudats de multivitamines |
MX2018011270A (es) * | 2016-03-22 | 2019-07-08 | Balchem Corp | Composiciones que comprenden colina. |
US11291683B2 (en) | 2016-04-01 | 2022-04-05 | Access Business Group International Llc | Bilayer tablets of B vitamins and process for preparing the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1767499A1 (de) * | 1968-05-16 | 1971-09-09 | Merck Patent Gmbh | Verfahren zur Herstellung haltbarer Vitaminzubereitungen |
NZ222664A (en) * | 1986-11-29 | 1990-06-26 | Vesta Med Pty Ltd | Pharmaceutical compositions containing pyridoxal as a source of vitamin b6 |
GB8900924D0 (en) * | 1989-01-17 | 1989-03-08 | Amco Chemie Handel | Compositions for use in enzyme deficiencies |
ATE147592T1 (de) * | 1990-02-05 | 1997-02-15 | Lifescience Corp | Vitamine und mineralien enthaltende nahrungszusätze |
GB2254556B (en) * | 1991-04-11 | 1995-04-12 | Fisons Plc | Formulations containing linolenic acid |
-
1993
- 1993-09-13 CN CN93117372A patent/CN1087517A/zh active Pending
- 1993-09-13 JP JP5227026A patent/JPH06192105A/ja active Pending
- 1993-09-13 CA CA002105177A patent/CA2105177A1/fr not_active Abandoned
- 1993-09-13 ZA ZA936723A patent/ZA936723B/xx unknown
- 1993-09-14 EP EP93114762A patent/EP0595005A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0595005A1 (fr) | 1994-05-04 |
JPH06192105A (ja) | 1994-07-12 |
CN1087517A (zh) | 1994-06-08 |
CA2105177A1 (fr) | 1994-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA936723B (en) | Pharmaceutical preparations for lowering homocysteine levels | |
PH30215A (en) | Pharmaceutical compounds | |
GB9319500D0 (en) | Pharmaceutical composition | |
HU9303261D0 (en) | Pharmaceutical compounds | |
GB2272375B (en) | Pharmaceutical composition | |
ZA931944B (en) | Pharmaceutical compounds | |
GB9201639D0 (en) | Pharmaceutical formulations | |
GB9221707D0 (en) | Pharmaceutical composition | |
PL308307A1 (en) | 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations | |
GB9222242D0 (en) | Pharmaceutical preparations for lowering homocysteine levels | |
GB9224169D0 (en) | Pharmaceutical compounds | |
GB9226724D0 (en) | Pharmaceutical compounds | |
ZA924061B (en) | Pharmaceutical composition | |
GB9211379D0 (en) | Pharmaceutical compounds | |
ZA931984B (en) | Pharmaceutical composition | |
GB9226895D0 (en) | Pharmaceutical compounds | |
ZA931332B (en) | Pharmaceutical compounds | |
GB9209028D0 (en) | Pharmaceutical compounds | |
GB9218112D0 (en) | Pharmaceutical compounds | |
GB9218092D0 (en) | Pharmaceutical compounds | |
GB9218091D0 (en) | Pharmaceutical compounds | |
GB9218090D0 (en) | Pharmaceutical compounds | |
GB9213058D0 (en) | Pharmaceutical compounds | |
GB9222650D0 (en) | Pharmaceutical compounds | |
GB9204774D0 (en) | Pharmaceutical formulations |